Sanjeev Krishna

From WikiMD's Wellness Encyclopedia

Sanjeev Krishna is a prominent scientist and professor known for his significant contributions to the field of malaria research. He is currently a Professor of Molecular Parasitology and Medicine at St George's, University of London.

Early Life and Education[edit | edit source]

Sanjeev Krishna was born in India and later moved to the United Kingdom for his higher education. He completed his MBBS and PhD from prestigious institutions, focusing on parasitology and infectious diseases.

Career[edit | edit source]

Krishna's career has been marked by his extensive research on malaria, particularly in understanding the biology of the Plasmodium parasite and developing new antimalarial drugs. He has published numerous scientific papers and has been a part of various clinical trials aimed at improving malaria treatment.

Research Contributions[edit | edit source]

One of Krishna's notable contributions is his work on the genomics of the malaria parasite, which has provided deeper insights into its drug resistance mechanisms. His research has also explored the host-pathogen interactions and the development of novel diagnostic tools for malaria.

Awards and Honors[edit | edit source]

Throughout his career, Sanjeev Krishna has received several awards and honors, including the Royal Society Fellowship and the Wellcome Trust Senior Investigator Award. His work has been recognized globally, making him a leading figure in malaria research.

Personal Life[edit | edit source]

Krishna is married and has two children. He is known for his dedication to his work and his passion for teaching and mentoring young scientists.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

Template:St George's, University of London

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD